1-4 of 4
Brenda Weigel, MSc, MD
Close
Sort by
Journal Articles

A Phase II Trial of Decitabine and Vorinostat in Combination with Chemotherapy for Relapsed/Refractory Acute Lymphoblastic Leukemia

Michael J Burke, MD, Jatinder Lamba, PhD, Brenda Weigel, MSc, MD, Veronika Bachanova, MD, Michael R. Verneris, MD, Jeffrey S. Miller, MD
Journal: Blood
Blood (2012) 120 (21): 4307.
https://doi.org/10.1182/blood.V120.21.4307.4307
Published: 2012
Journal Articles

Early Hematopoietic Stem Cell Transplant Is Associated with Improved Outcomes in Children with MDS,

Ellen C Christianson, Barb Trotz, BA, BSN, MSN, Qing Cao, MS, Emily Lipsitz, MD, Brenda Weigel, MSc, MD, Heather E. Stefanski, MD, PhD, Michael R Verneris, MD, Michael J Burke, MD, Angela Smith, MD, MS
Journal: Blood
Blood (2011) 118 (21): 4126.
https://doi.org/10.1182/blood.V118.21.4126.4126
Published: 2011
Journal Articles

Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) for Treatment of Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (ALL).

Michael Burke, MD, Barb Trotz, BA, BSN, MSN, Qing Cao, MS, Brenda Weigel, MSc, MD, Ashish Kumar, MBBS, PhD, Angela Smith, MD, MS, Michael Verneris, MD
Journal: Blood
Blood (2009) 114 (22): 3377.
https://doi.org/10.1182/blood.V114.22.3377.3377
Published: 2009
Journal Articles

Toll-Like Receptor-7 Agonist Directly Inhibits the Growth and Induces Apoptosis of MLL-AF9 Leukemia Cells in Vitro and in Vivo

Xueqing Liang, MD, PhD, Ashish Kumar, MBBS, PhD, Zhimei Wang, MD, Brenda Weigel, MSc, MD, Bruce R Blazar, M.D., Wei Chen, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 2989.
https://doi.org/10.1182/blood.V112.11.2989.2989
Published: 2008